6-K
QIAGEN N.V. Reports U.S. GAAP Quarterly Financial Results for Q3 2026
6-K
QIAGEN Reports Full Q3 2026 Results and Suspends Outlook Due to Pending EQT Private Equity Acquisition
6-K
QIAGEN N.V. Announces Planned Tender Offer by Crown NL Bidco B.V.
6-K
QIAGEN appoints Jonathan M. Pratt as Chief Executive Officer
6-K
QIAGEN N.V. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2026
6-K
QIAGEN Exceeds Q2 2026 Outlook and Reaffirms Full-Year Guidance